WaveMan
WaveMan · Company
BFLY · Butterfly Network, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

BFLY Butterfly Network (BFLY) Insider Trading, Ownership & Congress Trades

Medical Devices · X-ray apparatus & tubes & related irradiation apparatus · CIK 0001804176
Quote by TradingView
Form 144 · 14
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
147
13F, latest reported quarter

What the filings say about BFLY

Insiders, 180 days
-$98.1M net sold
1 buyer · 8 sellers · 8% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$20.4M
14 notices

Butterfly Network insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Butterfly Network, Inc. insiders sold a net $98.1M of stock across 155 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
DEVIVO JOSEPH
President & CEO
SELL
2026-10-08 SECtraded 2026-10-06
35,790
$358.6K
-10.5%
Context
  • 10 earlier Form 4 trades (code P or S) here by this insider (2 buys, 8 sales), the last on Sep 23, 2026.
  • +60.8% median (+60.8% mean) 90-day return after 2 previous buys.
  • The trade is 0.5% of the 7,311,930 shares held after it.
  • 1 other insider sold within 30 days.
  • 147 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO DEVIVO JOSEPH sold about $358.6K of BFLY under a 10b5-1 plan on Oct 6, 2026; 1 other insider sold within 30 days and 147 funds added in the latest 13F quarter.
Carlson Megan
CAO and SVP, Finance
SELL
2026-10-06 SECtraded 2026-10-02
10,114
$88.4K
-10.8%
Context
  • 6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Sep 4, 2026.
  • The trade is 2.5% of the 401,971 shares held after it.
  • 3 other insiders sold within 30 days.
  • 147 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CAO and SVP, Finance Carlson Megan sold about $88.4K of BFLY on Oct 2, 2026; 3 other insiders sold within 30 days and 147 funds added in the latest 13F quarter.
DEVIVO JOSEPH
President & CEO
SELL
2026-09-24 SECtraded 2026-09-23
3,169
$31.8K
-21.4%
Context
  • 9 earlier Form 4 trades (code P or S) here by this insider (2 buys, 7 sales), the last on Sep 22, 2026.
  • +60.8% median (+60.8% mean) 90-day return after 2 previous buys.
  • The trade is 0.0% of the 7,347,720 shares held after it.
  • 3 other insiders sold within 30 days.
  • 147 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO DEVIVO JOSEPH sold about $31.8K of BFLY under a 10b5-1 plan on Sep 23, 2026; 3 other insiders sold within 30 days and 147 funds added in the latest 13F quarter.
DEVIVO JOSEPH
President & CEO
SELL
2026-09-24 SECtraded 2026-09-22
2,811
$28.1K
-21.4%
Context
  • 8 earlier Form 4 trades (code P or S) here by this insider (2 buys, 6 sales), the last on Aug 10, 2026.
  • +60.8% median (+60.8% mean) 90-day return after 2 previous buys.
  • The trade is 0.0% of the 7,350,889 shares held after it.
  • 3 other insiders sold within 30 days.
  • 147 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO DEVIVO JOSEPH sold about $28.1K of BFLY under a 10b5-1 plan on Sep 22, 2026; 3 other insiders sold within 30 days and 147 funds added in the latest 13F quarter.
Carlson Megan
CAO and SVP, Finance
SELL
2026-09-09 SECtraded 2026-09-04
13,804
$100.8K
+3.7%
Context
  • 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Jul 31, 2026.
  • The trade is 3.3% of the 412,085 shares held after it.
  • 4 other insiders sold within 30 days.
  • 147 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CAO and SVP, Finance Carlson Megan sold about $100.8K of BFLY on Sep 4, 2026; 4 other insiders sold within 30 days and 147 funds added in the latest 13F quarter.
155 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 150 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$98.1M over 180 days
-$36.6M over 90 days · -$50.1M of it by a 10%+ holder
below 98% of Medical Devices
Congress
no House purchase disclosed in the last 12 months
Funds
147 funds bought in last quarter
more than 75% of Medical Devices
Revenue
+19.0% year over year
more than 70% of Medical Devices
Margin
-79.0% net margin
below 77% of Medical Devices
Buybacks
no share repurchases reported
Short interest
14.4% of the float short (float per yahoo 2026-10-26) · 4.8 days to cover · settled 2026-09-30
What changed in the last 30 days
Oct 8President & CEO DEVIVO JOSEPH sold $358.6K under a 10b5-1 plan (Oct 6)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 6Officer DEVIVO JOSEPH filed to sell $358.6K by Oct 6 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Oct 6CAO and SVP, Finance Carlson Megan sold $88.4K (Oct 2)
Oct 2Officer Carlson Megan filed to sell $88.4K by Oct 2 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.

Watch BFLY

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+232.4%12M
-11%+108%+228%+347%2025-102025-122026-022026-042026-062026-082026-10 2026-07-31 · ROBBINS LARRY sold $12.7M2026-07-15 · ROTHBERG JONATHAN M sold $12.7M2026-07-16 · ROTHBERG JONATHAN M sold $8.6M2026-07-17 · ROTHBERG JONATHAN M sold $7.9M2026-07-20 · ROTHBERG JONATHAN M sold $7.8M2026-08-14 · ROBBINS LARRY sold $7.2M2026-07-14 · ROTHBERG JONATHAN M sold $6.3M2026-08-17 · ROBBINS LARRY sold $5.2M2026-07-21 · ROTHBERG JONATHAN M sold $5.1M2026-08-13 · ROBBINS LARRY sold $4.6M2026-07-22 · ROTHBERG JONATHAN M sold $3.2M2025-12-03 · ROBBINS LARRY bought $2.4M2025-11-20 · ROBBINS LARRY bought $2.4M2025-11-19 · ROBBINS LARRY bought $2.4M2025-11-21 · ROBBINS LARRY bought $2.1M2026-08-13 · ROBBINS LARRY sold $2.1M2025-12-15 · ROTHBERG JONATHAN M sold $1.9M2026-01-07 · ROTHBERG JONATHAN M sold $1.9M2026-07-16 · ROTHBERG JONATHAN M sold $1.8M2026-03-05 · DEVIVO JOSEPH sold $1.8M2025-12-08 · ROTHBERG JONATHAN M sold $1.8M2026-07-07 · DEVIVO JOSEPH sold $1.6M2025-12-04 · ROBBINS LARRY bought $1.6M2026-08-13 · ROBBINS LARRY sold $1.6M2026-01-06 · ROTHBERG JONATHAN M sold $1.4M2026-01-08 · ROTHBERG JONATHAN M sold $1.4M2026-07-20 · DEVIVO JOSEPH sold $1.4M2025-11-26 · ROTHBERG JONATHAN M sold $1.4M2026-06-08 · Cashman Steve sold $1.4M2026-08-03 · ROBBINS LARRY sold $1.3M2025-11-24 · ROTHBERG JONATHAN M sold $1.2M2026-02-26 · Cashman Steve sold $1.1M2026-04-16 · Cashman Steve sold $1.0M2026-09-04 · Cashman Steve sold $1.0M2026-08-14 · Phanstiel S. Louise bought $999.5K2025-12-10 · ROTHBERG JONATHAN M sold $904.3K2025-12-08 · ROTHBERG JONATHAN M sold $738.1K2025-11-25 · ROTHBERG JONATHAN M sold $735.5K2025-11-25 · ROTHBERG JONATHAN M sold $735.5K2026-04-29 · Cashman Steve sold $724.3K2026-08-10 · DEVIVO JOSEPH sold $684.1K2025-12-16 · ROTHBERG JONATHAN M sold $617.5K2026-10-06 · DEVIVO JOSEPH filed to sell $358.6K2026-10-02 · Carlson Megan filed to sell $88.4K2026-09-23 · Schwartz Erica filed to sell $3.2M2026-09-23 · DEVIVO JOSEPH filed to sell $31.8K2026-09-22 · Schwartz Erica filed to sell $786.8K2026-09-22 · DEVIVO JOSEPH filed to sell $28.1K2026-09-04 · Carlson Megan filed to sell $100.8K2026-09-04 · Cashman Steve filed to sell $1.0M2026-09-02 · Caezza Nicholas filed to sell $13.9K2026-08-11 · Caezza Nicholas filed to sell $97.5K2026-08-10 · DEVIVO JOSEPH filed to sell $684.1K2026-08-10 · Carfora Dawn filed to sell $85.5K2026-07-31 · ROBBINS LARRY filed to sell $13.3M2026-07-31 · Carlson Megan filed to sell $541.4K2026-07-22 · ROTHBERG JONATHAN M filed to sell $4.3M2026-07-21 · ROTHBERG JONATHAN M filed to sell $5.1M2026-07-20 · Ku Victor filed to sell $318.4K2026-07-20 · Doherty John N. filed to sell $374.8K2026-07-20 · DEVIVO JOSEPH filed to sell $1.4M2026-07-20 · Doherty John N. filed to sell $7
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns BFLY: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
18,821,463 sh
$158.5M
GLENVIEW CAPITAL MANAGEMENT, LLC
14,335,055 sh
$120.7M
Hood River Capital Management LLC
13,190,130 sh
$111.1M
Fosun International Ltd
10,234,923 sh
$86.2M
VANGUARD CAPITAL MANAGEMENT LLC
8,559,346 sh
$72.1M

Congress trades in BFLY

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

BFLY planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
DEVIVO JOSEPH
Filed 2026-10-06
$358.6K
Carlson Megan
Filed 2026-10-02
$88.4K
Schwartz Erica
Filed 2026-09-23
$3.2M
DEVIVO JOSEPH
Filed 2026-09-23
$31.8K
Schwartz Erica
Filed 2026-09-22
$786.8K

BFLY mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Hood River New Opportunities Fund
$35.9M position · as of 2026-06-30
2.8%
State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF
$3.9M position · as of 2026-06-30
2.6%
ARK Genomic Revolution ETF
$33.9M position · as of 2026-07-31
2.2%
DWS Small Cap Core Fund
$16.0M position · as of 2026-06-30
1.4%
Calamos Timpani Small Cap Growth Fund
$9.7M position · as of 2026-07-31
1.3%
DWS Global Small Cap VIP
$982.4K position · as of 2026-06-30
1.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $98.1M sold by insiders over 180 days, 147 funds added last quarter, $20.4M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
PENBLFSMTDSIBNWRBYISRGTXGDXCMEWTMDXOMIRMD

BFLY financials

Revenue growth
+19.0%
XBRL, annual
Net margin
-79.0%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$112.1M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-66.8%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
-$28.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
n/a
no debt line filed
Cash flow to debt
n/a
no debt line filed
Return on equity
-35.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-25.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
-32.2%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
n/a
no share count filed
FCF yield
n/a
no share count filed
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$97.6M$82.1M$65.9M$73.4M
Gross profit$45.7M$48.8M$16.9M$39.5M
Operating income-$86.4M-$74.4M-$145.6M-$193.0M
Net income-$77.1M-$72.5M-$133.7M-$168.7M
EPS (diluted)-0.31-0.34-0.65-0.84
Operating cash flow-$12.7M-$41.7M-$98.8M-$169.1M
Cash$150.5M$88.8M$134.4M$162.6M
SEC XBRL, fiscal years, as known on 2026-10-28

BFLY Stock Sonar score 5/7 axes

Find similar shapesCompare

BFLY ranks highest on growth (82nd percentile) and institutional and government (75th), and lowest on insider conviction (27th), among Medical Devices peers.

ProfitGrowthInsidersInstitutionsRisk
Profitability
42
Inputs
  • Return on equity-35.5% · 44 pct, sector of 183
  • Return on assets-25.1% · 42 pct, sector of 214
  • Return on invested capitalpre-tax loss, no effective tax rate to apply
  • Return on capital employed-32.2% · 39 pct, sector of 188
Growth
82
Inputs
  • Revenue growth, YoY+19.0% · 70 pct, sector of 219
  • Backlog growth, YoY+111.9% · 94 pct, sector of 37
Insider conviction
27
Inputs
  • Net Form 4 buying (codes P and S), 180d-$97.7M · 2 pct, sector of 140
  • Insider buyers, 180d1 · 52 pct, sector of 142
Institutional and government
75
Inputs
  • Funds adding, latest quarter147 · 75 pct, sector of 191
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
50
Inputs
  • Short interest, % of float+14.4% · 9 pct, sector of 240
  • Recalls per $1B revenue, 3y0.00 per $1B · 100 pct, sector of 116
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+12.3% · 41 pct, sector of 198
2 not measured: Financial health, US patents
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

BFLY filings, in plain words

Are Butterfly Network insiders buying or selling BFLY?

In the 180 days to 2026-10-28, Butterfly Network insiders were net sellers, a net $98.1M: $999.5K of purchases and $99.1M of sales reported on Form 4, by 1 buyer and 8 sellers.

Are there planned insider sales of BFLY?

Yes. 14 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $20.4M of stock; the latest, by DEVIVO JOSEPH, was filed 2026-10-06.

Read the full summary

In the 180 days to 2026-10-28, Butterfly Network insiders were net sellers of BFLY, a net $98.1M across purchases and sales reported on Form 4 by 1 buyer and 8 sellers. Most of that figure, $50.1M, came from a holder of 10% or more rather than an officer or director. Sales outweighed purchases more than tenfold by value. 8% of the 39 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 14 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $20.4M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies